| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
REVIEW |
Divisions of Endocrinology, Diabetes and Metabolism (A.G.P., B.D.-H.), and Clinical Research (J.L.), Tufts-New England Medical Center, Boston, Massachusetts 02111; Harvard School of Public Health and Channing Laboratory (F.B.H.), Boston, Massachusetts 02115; and Bone Metabolism Laboratory (B.D.-H.), Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111
Address all correspondence and requests for reprints to: Anastassios G. Pittas, M.D., M.Sc., Division of Endocrinology, Diabetes and Metabolism, Tufts-New England Medical Center, 750 Washington Street, #268, Boston, Massachusetts 02111. E-mail: apittas{at}tufts-nemc.org.
Context: Altered vitamin D and calcium homeostasis may play a role in the development of type 2 diabetes mellitus (type 2 DM).
Evidence Acquisition and Analyses: MEDLINE review was conducted through January 2007 for observational studies and clinical trials in adults with outcomes related to glucose homeostasis. When data were available to combine, meta-analyses were performed, and summary odds ratios (OR) are presented.
Evidence Synthesis: Observational studies show a relatively consistent association between low vitamin D status, calcium or dairy intake, and prevalent type 2 DM or metabolic syndrome [OR (95% confidence interval): type 2 DM prevalence, 0.36 (0.16–0.80) among nonblacks for highest vs. lowest 25-hydroxyvitamin D; metabolic syndrome prevalence, 0.71 (0.57–0.89) for highest vs. lowest dairy intake]. There are also inverse associations with incident type 2 DM or metabolic syndrome [OR (95% confidence interval): type 2 DM incidence, 0.82 (0.72–0.93) for highest vs. lowest combined vitamin D and calcium intake; 0.86 (0.79–0.93) for highest vs. lowest dairy intake]. Evidence from trials with vitamin D and/or calcium supplementation suggests that combined vitamin D and calcium supplementation may have a role in the prevention of type 2 DM only in populations at high risk (i.e. glucose intolerance). The available evidence is limited because most observational studies are cross-sectional and did not adjust for important confounders, whereas intervention studies were short in duration, included few subjects, used a variety of formulations of vitamin D and calcium, or did post hoc analyses.
Conclusions: Vitamin D and calcium insufficiency may negatively influence glycemia, whereas combined supplementation with both nutrients may be beneficial in optimizing glucose metabolism.
This article has been cited by other articles:
 |
|
 |
|
  T. Kulie, A. Groff, J. Redmer, J. Hounshell, and S. Schrager Vitamin D: An Evidence-Based Review J Am Board Fam Med, November 1, 2009; 22(6): 698 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Wehr, S Pilz, N Schweighofer, A Giuliani, D Kopera, T R Pieber, and B Obermayer-Pietsch Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome Eur. J. Endocrinol., October 1, 2009; 161(4): 575 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Avenell, J. A. Cook, G. S. MacLennan, and G. C. McPherson Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438) Age Ageing, September 1, 2009; 38(5): 606 - 609. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Golan, I. Haggiag, P. Os, and J. Bernheim Calcium, Parathyroid Hormone, and Vitamin D: Major Determinants of Chronic Pain in Hemodialysis Patients Clin. J. Am. Soc. Nephrol., August 1, 2009; 4(8): 1374 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Luo, J. Wong, M. Brown, M. Hooper, L. Molyneaux, and D.K. Yue Hypovitaminosis D in Chinese type 2 diabetes: Lack of impact on clinical metabolic status and biomarkers of cellular inflammation Diabetes and Vascular Disease Research, July 1, 2009; 6(3): 194 - 199. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Lu, Z. Yu, A. Pan, F. B. Hu, O. H. Franco, H. Li, X. Li, X. Yang, Y. Chen, and X. Lin Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals Diabetes Care, July 1, 2009; 32(7): 1278 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-H. Gannage-Yared, R. Chedid, S. Khalife, E. Azzi, F. Zoghbi, and G. Halaby Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population Eur. J. Endocrinol., June 1, 2009; 160(6): 965 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Villegas, Y.-T. Gao, Q. Dai, G. Yang, H. Cai, H. Li, W. Zheng, and X. O. Shu Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study Am. J. Clinical Nutrition, April 1, 2009; 89(4): 1059 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Liu, J. B. Meigs, A. G. Pittas, N. M. McKeown, C. D. Economos, S. L. Booth, and P. F. Jacques Plasma 25-Hydroxyvitamin D Is Associated with Markers of the Insulin Resistant Phenotype in Nondiabetic Adults J. Nutr., February 1, 2009; 139(2): 329 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Introduction J. Am. Coll. Nutr., February 1, 2009; 28(Supplement_1): 69S - 72S. [Full Text] [PDF]
|
|
|
|
|
|
T. A. Nicklas, C. E. O'Neil, and V. L. Fulgoni III The Role of Dairy in Meeting the Recommendations for Shortfall Nutrients in the American Diet J. Am. Coll. Nutr., February 1, 2009; 28(Supplement_1): 73S - 81S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tremblay and J.-A. Gilbert Milk Products, Insulin Resistance Syndrome and Type 2 Diabetes J. Am. Coll. Nutr., February 1, 2009; 28(Supplement_1): 91S - 102S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Kris-Etherton, J. A. Grieger, K. F. Hilpert, and S. G. West Milk Products, Dietary Patterns and Blood Pressure Management J. Am. Coll. Nutr., February 1, 2009; 28(Supplement_1): 103S - 119S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bikle Nonclassic Actions of Vitamin D J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 26 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lamarche Review of the Effect of Dairy Products on Non-Lipid Risk Factors for Cardiovascular Disease J. Am. Coll. Nutr., December 1, 2008; 27(6): 741S - 746S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Penckofer, J. Kouba, D. E. Wallis, and M. A. Emanuele Vitamin D and Diabetes: Let the Sunshine In The Diabetes Educator, November 1, 2008; 34(6): 939 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pilz, W. Marz, B. Wellnitz, U. Seelhorst, A. Fahrleitner-Pammer, H. P. Dimai, B. O. Boehm, and H. Dobnig Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary Angiography J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3927 - 3935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Scragg Vitamin D and Type 2 Diabetes: Are We Ready for a Prevention Trial? Diabetes, October 1, 2008; 57(10): 2565 - 2566. [Full Text] [PDF]
|
|
|
|
|
|
N. G. Forouhi, J. Luan, A. Cooper, B. J. Boucher, and N. J. Wareham Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance: The Medical Research Council Ely Prospective Study 1990-2000 Diabetes, October 1, 2008; 57(10): 2619 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Wallis, S. Penckofer, and G. W. Sizemore The "Sunshine Deficit" and Cardiovascular Disease Circulation, September 30, 2008; 118(14): 1476 - 1485. [Full Text] [PDF]
|
|
|
|
|
|
J. P Reis, D. von Muhlen, and E. R Miller III Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur. J. Endocrinol., July 1, 2008; 159(1): 41 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Giovannucci, Y. Liu, B. W. Hollis, and E. B. Rimm 25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men: A Prospective Study Arch Intern Med, June 9, 2008; 168(11): 1174 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Talmor, E. Golan, S. Benchetrit, J. Bernheim, O. Klein, J. Green, and G. Rashid Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1059 - F1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lee and R. Chen Vitamin D as an Analgesic for Patients With Type 2 Diabetes and Neuropathic Pain Arch Intern Med, April 14, 2008; 168(7): 771 - 772. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. McCann and B. N. Ames Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J, April 1, 2008; 22(4): 982 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. de Boer, L. F. Tinker, S. Connelly, J. D. Curb, B. V. Howard, B. Kestenbaum, J. C. Larson, J. E. Manson, K. L. Margolis, D. S. Siscovick, et al. Calcium Plus Vitamin D Supplementation and the Risk of Incident Diabetes in the Women's Health Initiative Diabetes Care, April 1, 2008; 31(4): 701 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Lichtenstein, H. Rasmussen, W. W. Yu, S. R. Epstein, and R. M. Russell Modified MyPyramid for Older Adults J. Nutr., January 1, 2008; 138(1): 5 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Liang Seasonal Changes in Preprandial Glucose, A1C, and Blood Pressure in Diabetic Patients: Response to Honeyman et al. Diabetes Care, November 1, 2007; 30(11): e119 - e119. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
